Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors
about
Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironmentGenetically engineered ERα-positive breast cancer mouse models.High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.MMP-1 expression has an independent prognostic value in breast cancer.Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro.Overexpression of Ras homologous C (RhoC) induces malignant transformation of hepatocytes in vitro and in nude mouse xenografts.Standard of care and promising new agents for triple negative metastatic breast cancerProgesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.Annexin A8 identifies a subpopulation of transiently quiescent c-kit positive luminal progenitor cells of the ductal mammary epithelium.Triple-negative breast cancer: are we making headway at least?Phospho-specific Smad3 signaling: impact on breast oncogenesis.Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells.Cyclin A overexpression is associated with chemosensitivity to paclitaxel-based chemotherapy in patients with esophageal squamous cell carcinoma.Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast.The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer.Automated Quantitative Analysis of p53, Cyclin D1, Ki67 and pERK Expression in Breast Carcinoma Does Not Differ from Expert Pathologist Scoring and Correlates with Clinico-Pathological Characteristics.Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast CancerSilencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis.Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model.RNA inference-mediated caveolin-1 down-regulation decrease estrogen receptor alpha (ERα) signaling in human mammary epithelial cells.Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.Prognostic value of proliferation markers expression in breast cancer.High proliferation is associated with inferior outcome in male breast cancer patients.Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study.Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients.
P2860
Q26852398-E0503E11-48B7-4055-BB82-5E80289F7375Q33578641-2A840E48-A181-41C4-84F0-B69341EA5CB3Q33867326-25F7EBDF-10D0-426D-B00F-725AEA5F3043Q33991012-8A422185-5897-4009-A473-92C2203AB6D5Q34173527-08B95561-68A2-46CC-90AB-54BBDCC3DEA1Q34575426-860E4E2C-F524-447B-AE7E-36B9E648B645Q34774884-DBB627DE-F6A1-4DFF-A8A1-7FA0311AB394Q35113788-B153FE91-B916-4106-A4EF-2BA2DAB24889Q35213733-6F8ADFCD-79C9-4497-9589-EE96428D908AQ36061177-FCD4BB4C-4B33-436B-B7D1-3FB178A1868EQ36116217-823F29FE-0FDB-457B-B931-542AFED7A141Q36187896-6DFFA898-787D-4E0A-A2FD-C91718047072Q36424035-76D1D1C0-7B2B-4893-9428-50C5BEE6ACEBQ36503490-9F284BD7-4FF9-4087-99DC-D83D1C9A917CQ36903218-00E71CCA-368A-4C1B-8014-DEC5CF904A32Q37017051-DA5D9310-BA81-4B3C-AA6A-DD46DD37635FQ37057171-C054BE93-E1B4-450A-A981-8903C09DFB77Q37071327-BB460388-212A-453B-BF85-A8C8F5C4B5CFQ39552577-91903DA8-24D5-4E14-BC95-019553837BF4Q39711967-6E3B2FC1-0295-42A2-AF89-3614CC201EB6Q40951473-6B5BD61F-5842-4615-96E9-D25827B1FB79Q43692538-3B404C25-DF69-4F01-9DE3-96ACD33D8C51Q46532481-081FD7B2-1151-4DE3-8C55-F1C9FFAE283EQ53175662-14BB92CD-414A-4E0E-A718-F05CDA6A8B02Q54314758-328329D7-0CF8-4DF4-BE82-4336E246B53CQ54353413-928CA1BD-8629-47FC-80BB-442D97161CEA
P2860
Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Analysis of cyclins A, B1, D1 ...... e and other prognostic factors
@ast
Analysis of cyclins A, B1, D1 ...... e and other prognostic factors
@en
type
label
Analysis of cyclins A, B1, D1 ...... e and other prognostic factors
@ast
Analysis of cyclins A, B1, D1 ...... e and other prognostic factors
@en
prefLabel
Analysis of cyclins A, B1, D1 ...... e and other prognostic factors
@ast
Analysis of cyclins A, B1, D1 ...... e and other prognostic factors
@en
P2093
P2860
P356
P1433
P1476
Analysis of cyclins A, B1, D1 ...... e and other prognostic factors
@en
P2093
Mirva Söderström
Olli Carpen
Pia Boström
Pirkko Hirsimäki
Tero Vahlberg
Tuire Palokangas
Yrjö Collan
P2860
P2888
P356
10.1186/1756-0500-2-140
P577
2009-07-17T00:00:00Z
P5875
P6179
1039454465